Contact us today to learn more about OptiMSM , the purest, highest quality MSM on the market
In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
New England Journal of Medicine, 2023
It can be surprising, and for many, frustrating to feel healthier than ever while noticing an aging shift in their face
For patients with type 2 diabetes or prediabetes, this dual benefit of weight loss and glycemic control is particularly advantageous
ALCAR is able to cross the blood-brain barrier, allowing it to act as a powerful antioxidant